Granowitz Craig B — SEC Form 4 filings
SEC reporting owner CIK 1876655. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-03.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-02-12 to 2026-03-03. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 25.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| LEXICON PHARMACEUTICALS, INC. (LXRX) | SVP, Chief Medical Officer | 6 | — | — | 25 |
Form 4 filings — Granowitz Craig B
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-03 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 35,790 · Option exercise (M): 74,226 · Option exercise (M): 202,260 · Tax withholding (F): 109,098 @ $1.47 · Option exercise (M): 35,790 (derivative) · Option exercise (M): 74,226 (derivative) · +1 more | EDGAR |
| 2026-02-17 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 346,610 (derivative) @ $0 · Grant/award (A): 519,920 (derivative) @ $0 | EDGAR |
| 2025-03-03 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 27,917 · Option exercise (M): 35,790 · Option exercise (M): 74,227 · Tax withholding (F): 65,308 @ $0.67 · Option exercise (M): 27,917 (derivative) · Option exercise (M): 35,790 (derivative) · +1 more | EDGAR |
| 2025-02-18 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 910,170 (derivative) @ $0 · Grant/award (A): 606,780 (derivative) @ $0 | EDGAR |
| 2024-02-29 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Option exercise (M): 27,916 · Option exercise (M): 35,790 · Tax withholding (F): 31,265 @ $2.62 · Option exercise (M): 27,916 (derivative) · Option exercise (M): 35,790 (derivative) | EDGAR |
| 2024-02-12 | 4 | LEXICON PHARMACEUTICALS, INC. (LXRX) | Grant/award (A): 222,680 (derivative) @ $0 · Grant/award (A): 222,680 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1876655 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →